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INTRODUCTIONThoracic endovascular aortic repair (TEVAR) has been
the most important recent advance in the care of patients with
thoracic aortic disease. In appropriate patients, TEVAR has
reduced recovery times, major morbidity, and disease-
related mortality. Although it has transformed the care of
patients with descending thoracic aortic aneurysm, pene-
trating ulcers, complicated distal aortic dissection, and trau-
matic aortic injury, it is still a young therapy and there is much
to be learned about patient selection, contemporary imaging,
device design, procedural techniques, and follow-up. Many
specialties participate in the care of patients having TEVAR
and keeping up with new developments is essential.
The Society for Vascular Surgery® (SVS) sponsored a
series of continuing medical education courses, with the
syllabus printed as the very first Supplement A in the
Journal of Vascular Surgery in 2006. The Midwestern Vas-
cular Surgical Society is also committed to the continued
education of physicians, and has commissioned this syllabus
in conjunction with sponsoring advanced TEVAR courses
in the Midwest. Adult learning is at the core of medical
professionalism, and the spirit of these courses is to provide
a relaxed, small-group, peer-to-peer environment in eco-
nomical and accessible regional venues.
We are grateful to the many authors who gave their time
and effort to write these contributions. They are rewarded by
knowing that they have assisted safer performance of TEVAR
in clinical practice. It should be acknowledged that these
courses and this Supplement are complementary to required
Food and Drug Administration-approved, manufacturer-
sponsored, device certification training, and other excellent
educational pathways.
This syllabus builds on the knowledge that was avail-
able when TEVAR became commercially available in 2005
when the first Supplement was written. Clinical data have
blossomed with reports from many multicenter trials, novel
devices, larger registries with improved statistical power,
long-term follow-up, expert consensus statements, and a
randomized trial. Several procedural techniques, new
proven devices, and contemporary imaging methods are
reviewed; however, this is not a definitive summary collec-
tion. Although experienced authors from multiple involved
specialties have been commissioned, there remains substan-
tial diversity in techniques and clinical algorithms. Investi-
gational devices hold hope for broader anatomic applicabil-
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reminds us that newer is not always better. Clearly, more
research and updated information will be forthcoming.
TEVAR devices and aneurysm data. First, contempo-
rary outcomes in open repair of the thoracic and thoraco-
abdominal aorta are discussed by Drs CW Acher and Mimi
Wynn from the University of Wisconsin. They establish that
complications are substantially reduced at centers of excel-
lence with modern techniques and teams. Next, Dr Sean
Lyden from the Cleveland Clinic details and contrasts the
commercially available devices and deployment systems.
His colleague, Dr Roy Greenberg, then describes many of
the investigational devices that are undergoing evaluation.
These two articles illustrate the rapid and dynamic progress
being made in the TEVAR field. The results of pivotal
regulatory clinical trials in the United States are reviewed
and compared by Drs Manuel Garcia-Toca and Mark Es-
kandari from Northwestern.
Challenging pathologies. The second group of arti-
cles describes the position of TEVAR for aortic diseases
other than elective aneurysm repair. Drs Paul DiMusto,
Dave Williams, Himanshu Patel, Santi Trimarchi, Jon Elia-
son, and Gib Upchurch comprehensively review endovas-
cular management of aortic dissection, including tech-
niques of fenestration and stenting as well as stent grafting.
They present in an organized manner the substantial amount
of data that have emerged about the care of this difficult
problem. Next, Dr Himanshu Patel and his colleagues at the
University of Michigan address the vexing problems of my-
cotic aneurysms and aortic fistulas and the potential roles of
TEVAR. Dr Girma Tefera from the University of Wisconsin
discusses the utility and techniques of TEVAR for patients
with traumatic aortic injury. In this application, TEVAR has
become the dominant treatment option.
Skills, imaging, and techniques. Learning new proce-
dures remains one of the most interesting aspects in mod-
ern practice of medicine, and this series of articles details
technical considerations common to TEVAR for all indica-
tions. Dr Jean Starr from Ohio State University starts with
gathering together skill sets, supplies, and teams. These are
essential aspects for a successful TEVAR program. In a
well-illustrated article on intraprocedural imaging, Dr Matt
Eagleton from the Cleveland Clinic discusses new imaging
techniques and the practical applications for TEVAR. It has
been said by a pioneer of endovascular medicine, Dr Char-
lie Strother, “If I can see it, I can treat it.” Although heavy
in jargon, this article is mandatory reading for those who
want to be up-to-date on these critical technologic ad-
vances. The next article focuses on new concepts for provi-
sion of access and is written by Dr Brian Peterson from
Saint Louis University. Large sheath insertion during
TEVAR and the risk of iliofemoral artery rupture remains a
daunting concern.
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visceral vessels. Drs Jon Matsumura and Addi Rizvi cover the
analysis of data that led to the SVS Practice Guidelines about
left subclavian artery revascularization. Then, Drs Raghuveer
Vallabhaneni and Luis Sanchez from Washington University
describe open techniques for arch vessel reconstruction. This
is nicely complemented by the following article on endovas-
cular techniques for arch vessel preservation by Drs Matt
Longo and Iraklis Pipinos at the University of Nebraska. Dr
Sunita Srivastava from the Cleveland Clinic has written an
outstanding review on visceral reconstruction techniques.
These three articles catalogue the innovation captured in these
hybrid TEVAR procedures. The last article in this group, by
Drs Addi Rizvi and Tim Sullivan from Minneapolis Heart
Institute, clearly presents the many important aspects of spinal
cord protection during TEVAR.
After the procedure. Endoleak management and
postoperative surveillance are covered by Dr Joseph RicottaII, in an article that details data found in different trials and
contrasts endoleak distribution with TEVAR and EVAR.
Other late complications are described by Drs Pegge
Halandras and Ross Milner from Loyola University. In the
last article, Dr Gary Seabrook from the Medical College of
Wisconsin provides a demonstration of accurate coding of
TEVAR procedures.
The Midwestern Vascular Surgical Society and the
many talented authors appreciate the privilege of contrib-
uting to this Supplement and sincerely hope that readers
find the content useful in further developing TEVAR pro-
grams and providing contemporary care for patients suffer-
ing from thoracic aortic diseases.
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